Department of Radiology, Division of Vascular and Interventional Radiology, University of Missouri, Missouri, Columbia.
Diagn Interv Radiol. 2023 Nov 7;29(6):794-799. doi: 10.4274/dir.2022.221622. Epub 2023 Mar 24.
To determine if mechanical thrombectomy (MT) for submassive pulmonary embolism (PE) positively impacts length of hospital stay (LOS), intensive care unit stay (ICU LOS), readmission rate, and in-hospital mortality compared with conservative therapy.
This was a retrospective review of all patients with submassive PE who either underwent MT or conservative therapy (systemic anticoagulation and/or inferior vena cava filter) between November 2019 and October 2021. Pediatric patients (age <18) and those with low-risk and massive PEs were excluded from the study. Patient characteristics, comorbidities, vitals, laboratory values (cardiac biomarkers, hospital course, readmission rates, and in-hospital mortality) were recorded. A 2:1 propensity score match was performed on the conservative and MT cohorts based on age and the PE severity index (PESI) classification. Fischer's exact test, Pearson's χ2 test, and Student's t-tests were used to compare patient demographics, comorbidities, LOS, ICU LOS, readmission rates, and mortality rates, with statistical significance defined as < 0.05. Additionally, a subgroup analysis based on PESI scores was assessed.
After matching, 123 patients were analyzed in the study, 41 in the MT cohort and 82 in the conservative therapy cohort. There was no significant difference in patient demographics, comorbidities, or PESI classification between the cohorts, except for increased incidence of obesity in the MT cohort ( = 0.013). Patients in the MT cohort had a significantly shorter LOS compared with the conservative therapy cohort (5.37 ± 3.93 vs. 7.76 ± 9.53 days, = 0.028). However, ICU LOS was not significantly different between the cohorts (2.34 ± 2.25 vs. 3.33 ± 4.49, = 0.059). There was no significant difference for in-hospital mortality (7.31% vs. 12.2%, = 0.411). Of those that were discharged from the hospital, there was significantly lower incidence of 30-day readmission in the MT cohort (5.26% vs. 26.4%, < 0.001). A subgroup analysis did not demonstrate that the PESI score had a significant impact on LOS, ICU LOS, readmission, or in-hospital mortality rates.
MT for submassive PE can reduce the total LOS and 30-day readmission rates compared with conservative therapy. However, in-hospital mortality and ICU LOS were not significantly different between the two groups.
比较机械血栓切除术(MT)与保守治疗(全身抗凝和/或下腔静脉滤器)对亚大块肺栓塞(PE)患者的住院时间(LOS)、重症监护病房(ICU)住院时间(ICU LOS)、再入院率和院内死亡率的影响。
本研究为回顾性分析 2019 年 11 月至 2021 年 10 月间行 MT 或保守治疗(全身抗凝和/或下腔静脉滤器)的亚大块 PE 患者。排除儿科患者(年龄<18 岁)和低危、大块 PE 患者。记录患者特征、合并症、生命体征、实验室值(心脏生物标志物、住院过程、再入院率和院内死亡率)。根据年龄和 PE 严重指数(PESI)分类对保守治疗和 MT 两组进行 2:1 倾向评分匹配。采用 Fisher 确切检验、Pearson χ2 检验和 Student t 检验比较患者人口统计学特征、合并症、LOS、ICU LOS、再入院率和死亡率,以 P<0.05 为差异有统计学意义。此外,还进行了基于 PESI 评分的亚组分析。
匹配后,123 例患者纳入研究,MT 组 41 例,保守治疗组 82 例。两组患者在人口统计学特征、合并症或 PESI 分类方面无显著差异,除 MT 组肥胖发生率较高( = 0.013)外。MT 组 LOS 显著短于保守治疗组(5.37±3.93 比 7.76±9.53 天, = 0.028)。然而,两组 ICU LOS 无显著差异(2.34±2.25 比 3.33±4.49, = 0.059)。院内死亡率无显著差异(7.31%比 12.2%, = 0.411)。出院患者中,MT 组 30 天再入院率显著较低(5.26%比 26.4%, <0.001)。亚组分析表明,PESI 评分对 LOS、ICU LOS、再入院或院内死亡率无显著影响。
与保守治疗相比,MT 治疗亚大块 PE 可缩短总 LOS 和 30 天再入院率。然而,两组患者的院内死亡率和 ICU LOS 无显著差异。